Grey zones and emerging scrutiny GLP-1 friendly as implied disease claim: The terms GLP-1 friendly, GLP-1 support, and natural GLP-1 booster can be risky
How does the mechanism of Ozempic differ from insulin
The study, posted May 21 on the American Society of Clinical Oncology website, found that people taking GLP-1 drugs were less likely to see certain obesity-related cancers spread, including lung, breast, colorectal and liver cancers
These choices are often based on personal experience rather than clinical evidence, making provider guidance important
In one report, a 52-year-old woman experienced nausea, chills, vomiting and diarrhea and was subsequently hospitalized for septic shock with multi-organ failure secondary to Pseudomonas fluorescens infection after getting an IV vitamin infusion at her home